This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Vijaya Pattabiraman, PhD
Co-founder and CTO at Bright Peak Therapeutics

Profile

Vijaya Pattabiraman is a co-founder of Bright Peak Therapeutics and serves as Chief Technology Officer. Dr. Pattabiraman has made seminal contributions to Bright Peak’s technology and brings in extensive expertise and know-how in peptide and protein sciences. He has more than 15 years of experience in biomolecules, small molecules discovery and development for academic and translational research. He is co-inventor on multiple patents and has co-authored several peer-reviewed publications, book chapters in the field of chemical protein synthesis, peptide antibiotics and small-molecules. Dr. Pattabiraman has fostered many academic and biotech collaborations and leads a multi-disciplinary global team. He is also a co-founder of Synple Chem, a start-up focused on automation in chemistry. He received his Ph.D. in organic chemistry from the University of Alberta, Canada and performed his postdoctoral studies with Prof. Bode at University of Pennsylvania, USA and at ETH Zürich, Switzerland.

Agenda Sessions

  • Novel Chemistry Platform Technologies for Creating Next-generation Precision Immunotherapies

    10:30